VANCOUVER, BRITISH COLUMBIA--(Marketwire - Feb. 6, 2009) - Allon Therapeutics Inc. (TSX:NPC) announced today that its investor relations program has been ranked by IR Magazine’s survey of Canadian investors and analysts as the Best Overall Investor Relations Program for small-cap Canadian companies.
